Sanofi (SNY) Reports Positive Results in Phase 3 trial for Toujeo in Children & Adolescents with Type 1 Diabetes; CHMP Adopts Positive Opinion for Expanded Indication
Go back to Sanofi (SNY) Reports Positive Results in Phase 3 trial for Toujeo in Children & Adolescents with Type 1 Diabetes; CHMP Adopts Positive Opinion for Expanded Indication| SANOFI (NASDAQ: SNY) | Delayed: 42.48 -0.66 (1.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.14 | 52 Week High | $44.76 | |||
| Open | $42.75 | 52 Week Low | $36.81 | |||
| Day High | $42.77 | P/E | N/A | |||
| Day Low | $42.34 | EPS | $0.00 | |||
| Volume | 2,244,770 | |||||
